~~<i id='A774DBC572'><strike id='A774DBC572'><tt id='A774DBC572'><pre id='A774DBC572'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：fashion 2025-08-19 12:15:26 - browse：297

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： PBMs drew scrutiny in House hearing — and so did pharma

explore

focus

entertainment

hotspot

focus

AdobeSANDIEGO—NeurocrineBiosciencesannouncedonTuesdaythatanexperimentaldrugforcongenitaladrenalhyper

WSS

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Ask STAT: What do you want to know about ChatGPT in medicine?

'A game

New guidelines on severe brain injury complicate already difficult decisions

Eli Lilly CEO gives to Mike Pence presidential super PAC

Patients, doctors press FTC to beef up hospital merger scrutiny

focus

fashion

explore

In age of alternative facts, a scholarly course on calling out crap

White House Covid adviser calls on docs to combat misinformation

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The unintended consequences of overturning Roe v. Wade

Activists slam private health insurers over coverage restrictions

CDC concerned about possible undetected monkeypox spread in U.K.

Wildfire smoke exposes gaps in outdoor worker protections

Transgender sports debate: Physicians say bans are health issue

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Akili changes sales model for its ADHD video game treatment

focus

Why are elite athletes different? Take a look at their microbes

Donald Trump's relentless attacks on special counsel Jack Smith

The science behind Janet Jackson's pregnancy at 49

The struggle to figure out which patients 'deserve' Wegovy

The story of mRNA: From a loose idea to a tool that may help curb Covid

Free Covid tests will again be offered to all U.S. households

entertainment

entertainment

hotspot

focus